Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    Asia Pacific Automated Breast Ultrasound Systems (ABUS) Market Forecast 2028 By Product (Automated Breast Ultrasound Systems, Automated Breast Volume Scanner), By End-Use (Hospitals, Diagnostic Imaging Centers), Research Report, Country Outlook (Japan, China, India, South Korea, Australia, Malaysia, Indonesia, Thailand, Singapore, Taiwan, Philippines, Vietnam), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
    Published Date: September 2022   |   Report ID: GR1064   |   Delivery: PDF  Request Free Sample

    Asia Pacific Automated Breast Ultrasound Systems Market size crossed USD 600 million in 2021 and is anticipated to observe around 15% growth rate between 2022 and 2028.

    The incidence of breast cancer is increasing at a worrying rate across the region. Factors, such as environmental conditions, obesity, hormonal changes, and excessive alcohol consumption can escalate the risk of breast cancer. Mammography systems have restricted capabilities with respect to detecting tumor in dense breast tissues, thereby persuading ABUS manufacturers to expand their product portfolio.

    Asia Pacific Automated Breast Ultrasound Systems Market

    Get more details on this report - Request Free Sample PDF

    Asian women are 75-80% likely to be dense breasted. According to the National Center for Biotechnology Information (NCBI), Chinese women have denser breast tissues as compared to other ethnicities. ABUS technology makes it a lot easier to detect tumors in dense breasts as it creates 3D images, giving physicians better clarity on the severity of the condition. China had recorded over 20% to 30% rise in breast cancer over past decade, while high incidence of the disease was also witnessed in New Zealand and Australia.

    Impact of COVID-19 on demand for ABUS in APAC

    The COVID-19 pandemic had a negative influence on the Asia Pacific automated breast ultrasound systems market growth. The travel and movement restrictions imposed by regional governments made it very difficult for breast cancer patients to get their regular check-ups done. This caused a steep decline in the sales of ABUS and ABVS machines. However, the post-pandemic period looks promising as the region’s healthcare industry is gradually recovering, thereby fueling the utilization of ABUS/ABVS technologies. Efforts from healthcare organizations to encourage women towards early diagnosis of diseases after infection could bolster the industry landscape.

    Asia Pacific Automated Breast Ultrasound Systems Market, By Product

    The ABUS segment will register significant CAGR through 2028. Automated Breast Ultrasound Systems (ABUS) are considered one of the most effective breast cancer detection technologies as they can create high-resolution 3D images with greater accuracy. This will give doctors a better understanding of their patient’s condition. They have also successfully overcome the limitations associated with mammography systems, such as detecting cancer in dense breast tissues.

    Asia Pacific Market, By Country

    China automated breast ultrasound systems market will reach USD 440 million revenue by 2028, due to the consistent growth in the prevalence of breast cancer across the country. A large share of women with dense breast tissues will opt for ABUS solutions as they can effectively detect cancer in such tissues. The Government of China has also initiated several programs to promote ultrasound screening for breast cancer detection. These efforts will generate a robust demand for ABUS across the country’s hospitals and diagnostic centers.

    Competitive Industry Landscape

    Major players involved in the Asia Pacific automated breast ultrasound systems (ABUS) market include Canon Medical Systems, GE Healthcare, Theraclion, Hitachi Ltd., Philips, Siemens AG, and SonoCine Inc.

    Strategic partnerships across the global industry will create new prospects for these companies. Advantages of modern technologies such as AI will encourage manufacturers to integrate them within their diagnostic products. Collaborations between ABUS providers will help them develop products that offer fast and more accurate automated ultrasound examinations.

    Frequently Asked Question(FAQ) :

    How big is the Asia Pacific ABUS market?
    The market size for automated breast ultrasound systems (ABUS) in Asia Pacific was more than USD 600 million in 2021 and is expected to record over 15% CAGR during the forecast period 2022-28.
    Why is the demand for ABUS technologies growing in APAC?
    Asia Pacific market size from the ABUS product segment will register a healthy growth rate through 2028 as it can deliver high-resolution 3D images with greater accuracy, giving doctors a better understanding of a patient’s condition.
    Why is the use of automated breast ultrasound systems increasing in China?
    China ABUS industry value is predicted to surpass USD 440 million by 2028 as the country is witnessing a worrying increase in the prevalence of breast cancer.
    Who provides automated breast ultrasound systems for the APAC market?
    The leading organizations operating in the market include GE Healthcare, Theraclion, Hitachi Ltd., Canon Medical Systems, Philips, Siemens AG, and SonoCine Inc., among many others.

    Get this research report on Asia Pacific Automated Breast Ultrasound Systems Market customized according to your business requirements.

    report-purchase - logo Buy Now

    Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team


     [email protected]